UNSPSC 51131827: Eltrombopag olamine

This classification denotes an agent affecting blood and body fluid C25H22N4O4.2C2H7NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4U07F515LG, chemically known as (1,1'-biphenyl)-3-carboxylic acid, 3'-((2z)-(1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene)hydrazino)-2'-hydroxy-, compound with 2-aminoethanol (1:2), but more generally known as eltrombopag olamine, which bears US NIH Compound Identifier 9915926.

UNSPSC 51131827 Eltrombopag olamine is a Commodity code that nominally covers a pharmaceutical active ingredient used in blood disorder treatment, but the recent state and local procurement activity tagged under this code does not reflect pharmaceutical procurement. Instead, Sourcewell, a State of Minnesota local government unit and service cooperative, posted RFP #061626 on May 12, 2026 for Law Enforcement Equipment — a scope entirely outside the pharmaceutical domain. The mismatch between the code's stated content and the actual solicitation suggests either a tagging error in the state and local procurement source or that this code sees minimal relevant activity in public-sector contracting. The single available opportunity provides no decision-relevant signal about legitimate demand for eltrombopag olamine or related pharmaceutical products under this UNSPSC designation.

The source contains no additional state and local contract opportunities under this code, no geographic concentration pattern, and no evidence of repeat issuing bodies or established procurement patterns. The law enforcement equipment RFP, while a valid Sourcewell cooperative vehicle spanning multiple Washington counties and nationwide participating entities with a June 16, 2026 deadline, bears no relation to the pharmaceutical scope the code nominally represents. Firms pursuing state and local opportunities in this code should verify current activity through direct searches of procurement portals in their target jurisdictions, as the available record does not support active, category-aligned demand.